Filtered By:
Source: Acta Pharmacologica Sinica
Management: Hospitals
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma.
This study may have important translational impacts in precise treatment of HCC.
PMID: 32541921 [PubMed - as supplied by publisher]
Source: Acta Pharmacologica Sinica - June 14, 2020 Category: Drugs & Pharmacology Authors: Feng J, Lu PZ, Zhu GZ, Hooi SC, Wu Y, Huang XW, Dai HQ, Chen PH, Li ZJ, Su WJ, Han CY, Ye XP, Peng T, Zhou J, Lu GD Tags: Acta Pharmacol Sin Source Type: research
